Plasma Extracellular Vesicle miRNA Profiles Distinguish Chronic Obstructive Pulmonary Disease Exacerbations and Disease Severity

Plasma Extracellular Vesicle miRNA Profiles Distinguish Chronic Obstructive Pulmonary Disease Exacerbations and Disease Severity

Hannah E O’Farrell, Rayleen V Bowman, Kwun M Fong, Ian A Yang Faculty of Medicine, the University of Queensland, Brisbane, QLD, AustraliaCorrespondence: Hannah E O’Farrell, Faculty of Medicine, the University of Queensland, Brisbane, QLD, Australia, Tel +61 07 3139 4110, Email hannah.ofarrell@uq.net...

Full description

Bibliographic Details
Main Authors:	O'Farrell HE, Bowman RV, Fong KM, Yang IA
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-11-01
Series:	International Journal of COPD
Subjects:	copd exacerbations extracellular vesicles mirnas
Online Access:	https://www.dovepress.com/plasma-extracellular-vesicle-mirna-profiles-distinguish-chronic-obstru-peer-reviewed-fulltext-article-COPD

Similar Items

Diaphragm Ultrasound is an Imaging Biomarker that Distinguishes Exacerbation Status from Stable Chronic Obstructive Pulmonary Disease
by: An TJ, et al.
Published: (2022-01-01)

Managment acute exacerbation of chronic obstructive pulmonary disease
by: Pavlović Tanja, et al.
Published: (2018-01-01)

[Acute exacerbations in Chronic Obstructive Pulmonary Disease (COPD)]
by: Domenico Lorenzo Urso
Published: (2017-07-01)

Static and dynamic hyperinflation during severe acute exacerbations of chronic obstructive pulmonary disease
by: van Geffen WH, et al.
Published: (2018-04-01)

Blood miRNAs Are Linked to Frequent Asthma Exacerbations in Childhood Asthma and Adult COPD
by: Anshul Tiwari, et al.
Published: (2022-04-01)

Predictors of re-exacerbation after an index exacerbation of chronic obstructive pulmonary disease in the REDUCE randomised clinical trial
by: Brigitte Engel, et al.
Published: (2017-05-01)

Molecular detection of respiratory pathogens and typing of human rhinovirus of adults hospitalized for exacerbation of asthma and chronic obstructive pulmonary disease
by: Fanny Wai-san Ko, et al.
Published: (2019-09-01)

Variability of Blood Eosinophil Count at Stable-State in Predicting Exacerbation Risk of Chronic Obstructive Pulmonary Disease
by: Kwok WC, et al.
Published: (2023-06-01)

Serum Troponin-I as a prognostic marker in acute exacerbated chronic obstructive pulmonary disease patients
by: Abdel Rahim I. Youssef, et al.
Published: (2013-10-01)

Microorganisms resistant to conventional antimicrobials in acute exacerbations of chronic obstructive pulmonary disease
by: Cristina Estirado, et al.
Published: (2018-06-01)

Frequent exacerbators of chronic obstructive pulmonary disease have distinguishable sputum microbiome signatures during clinical stability
by: Xiaomin Dang, et al.
Published: (2022-12-01)

Plasma Extracellular Vesicle miRNAs Can Identify Lung Cancer, Current Smoking Status, and Stable COPD
by: Hannah E. O’Farrell, et al.
Published: (2021-05-01)

Management of chronic obstructive pulmonary disease exacerbations in Internal Medicine
by: Gelorma Belmonte, et al.
Published: (2013-03-01)

Prediction and course of symptoms and lung function around an exacerbation in chronic obstructive pulmonary disease
by: van den Berge Maarten, et al.
Published: (2012-06-01)

The role of infectious pathogens in exacerbation of chronic obstructive pulmonary disease in Dakahlia Governorate
by: Elsayed Ahmed Fahmy, et al.
Published: (2020-11-01)

AN OBSERVATIONAL SYUDY ON THE ROLE OF DECAF SCORE IN PREDICTING PROGNOSIS IN PATIENTS WITH ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
by: Rituporna Chanda, et al.
Published: (2023-06-01)

Intensive care unit of Chest Department Zagazig University Hospitals’ experience in management of acute exacerbations of chronic obstructive pulmonary disease
by: Mohamed Awad Mohamed, et al.
Published: (2013-04-01)

Stability of Frequent Exacerbator Phenotype in Patients with Chronic Obstructive Pulmonary Disease
by: Krachunov Iliya, et al.
Published: (2018-12-01)

Iron in airway macrophages and infective exacerbations of chronic obstructive pulmonary disease
by: Terence Ho, et al.
Published: (2022-01-01)

Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)
by: Sean Duffy, et al.
Published: (2017-06-01)

Thrombelastography and Conventional Coagulation Markers in Chronic Obstructive Pulmonary Disease: A Prospective Paired-Measurements Study Comparing Exacerbation and Stable Phases
by: Ema Rastoder, et al.
Published: (2024-02-01)

Metabolic Syndrome in Early Chronic Obstructive Pulmonary Disease: Gender Differences and Impact on Exacerbation and Medical Costs
by: Choi HS, et al.
Published: (2019-12-01)

REQUENT EXACERBATORS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: FROM RESEARCH TO CLINICAL PRACTICE
by: Richard Hewitt, et al.
Published: (2015-05-01)

Gaining insights into chronic obstructive pulmonary disease exacerbation through emerging biomarkers and the chronic obstructive pulmonary disease assessment test score
by: Megha Hegde, et al.
Published: (2024-03-01)

“Frequent exacerbator” is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease
by: Tomioka R, et al.
Published: (2016-02-01)

Oxidative Stress Biomarkers in Chronic Obstructive Pulmonary Disease Exacerbations: A Systematic Review
by: Elisabetta Zinellu, et al.
Published: (2021-04-01)

Value of copeptin and C-reactive protein in acute exacerbation of chronic obstructive pulmonary disease
by: Tamer Said Morsi, et al.
Published: (2014-10-01)

Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study
by: Whittaker H, et al.
Published: (2022-03-01)

Hypomagnesaemia in Acute Exacerbation Chronic Obstructive Airway Disease; Association with Anthonisen’s Levels of Exacerbation
by: Javaira Aziz, et al.
Published: (2022-06-01)

The Impact of Exacerbation History on the Safety and Efficacy of Aclidinium in Patients with Chronic Obstructive Pulmonary Disease and Increased Cardiovascular Risk: ASCENT-COPD Trial
by: Wise RA, et al.
Published: (2021-03-01)

Increased Red Blood Cell Distribution Predicts Severity of Chronic Obstructive Pulmonary Disease Exacerbation
by: Elias Saad, et al.
Published: (2023-05-01)

Long-Term Azithromycin Maintenance Treatment in Patients with Frequent Exacerbations of Chronic Obstructive Pulmonary Disease
by: Talman S, et al.
Published: (2021-03-01)

The Combination of Hemogram Indexes to Predict Exacerbation in Stable Chronic Obstructive Pulmonary Disease
by: Xuanqi Liu, et al.
Published: (2020-12-01)

Predictive factors for exacerbation and re-exacerbation in chronic obstructive pulmonary disease: an extension of the Cox model to analyze data from the Swiss COPD cohort
by: Pascal Urwyler, et al.
Published: (2019-02-01)

Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis
by: Singh D, et al.
Published: (2023-07-01)

Airway gene expression of IL-1 pathway mediators predicts exacerbation risk in obstructive airway disease
by: Baines KJ, et al.
Published: (2017-02-01)

Association Between Statin Use and Exacerbation of Chronic Obstructive Pulmonary Disease Among Patients Receiving Corticosteroids
by: Huang YJ, et al.
Published: (2021-03-01)

Serum Procalcitonin in Chronic Obstructive Pulmonary Disease
by: Farzaneh Akbari, et al.
Published: (2021-03-01)

Effect of timing of bronchodilator therapy initiation on exacerbations in patients with chronic obstructive pulmonary disease: a retrospective cohort study
by: Hideyasu Yamada, et al.
Published: (2022-09-01)

Determinants of exacerbation risk in patients with COPD in the TIOSPIR study
by: Calverley PMA, et al.
Published: (2017-11-01)